Dynamic Synthesis, Novasep to merge

• Publisher: Elsevier Science
• Year: 2004
• Weight: 36 KB
• Volume: 2004
• Category: Article
• ISSN: 1351-4180
• DOI: 10.1016/s1351-4180(04)00674-9

✦ Synopsis

Quest's ligand technology is being used by Pfizer for the process development and manufacture of new therapeutic compounds. The relationship covers a range of Chiral Quest's catalysts and ligands. This achievement further supports and develops Chiral Quest's goal of becoming a leading, high value technology provider of products and services to the chiral therapeutics industry.